In addition, bortezomib treatment in MCL induces the transcription of a zinc finger protein (PRDM1, Blimp1) required for NOXA-induced apoptosis in MCLs and PRDM1 expression, which are critical for bortezomib efficacy in MCL [81]. This evidence concerns the gene PRDM1 and mantle cell lymphoma.